UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% during the fourth quarter, Holdings Channel reports. The firm owned 9,940 shares of the healthcare conglomerate’s stock after selling 521 shares during the period. Kingsview Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,028,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group during the third quarter worth about $27,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $37,000. Friedenthal Financial acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $51,000. Finally, Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at approximately $55,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 0.6 %

UNH opened at $526.68 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $484.69 billion, a price-to-earnings ratio of 33.98, a PEG ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a fifty day moving average price of $529.18 and a 200 day moving average price of $564.30.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research reports. TD Cowen raised their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.